Consolidation to gather pace in Europe's lab testing market
This article was originally published in Clinica
Over the next five to seven years, the number of small- and medium-throughput laboratory testing sites in Europe will reduce dramatically by around 10% annually, predicts a new study. This trend will be particularly pronounced in countries like France, Italy and Spain, which are currently oversupplied with labs of this size, says the study on workload and workstation consolidation in Europe carried out by Brussels-based consultants Glover Leonard Redshaw.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.